Kraig Biocraft Laboratories Inc (KBLB)

[SPalmer1970]

The only difference between drug companies and KBLB is that the drug companies have products (Pills/Medicine), while KBLB does not have any proven spools of silks. In addition, the drug companies have met the requirements to uplist, while KBLB is struggling to get their stuff together, since it has been taken way too long.

Yes, it is still a stupid move, in my opinion. The process to reverse split and uplist to NASDAQ was too rushed by Kim, and I believe Kim started the motion just to get out of OTC market (some calls it a sewage pit) all because of slumping of share price. No, the slumping of share price occurs because KBLB is not selling any silks and not obtaining any revenues and Kim is not communicating and investors are not very impressed (despite the technology).